ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Influenza Virus Rapid Antigen Test Kit Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-10D16892
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Influenza Virus Rapid Antigen Test Kit Market Research Report 2024
BUY CHAPTERS

Global Influenza Virus Rapid Antigen Test Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-10D16892
Report
November 2025
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BD
Abbott
Quidel
Roche
Actim
Denka
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
DAAN Gene

Influenza Virus Rapid Antigen Test Kit Market Size

The global Influenza Virus Rapid Antigen Test Kit market is projected to grow from US$ 223 million in 2024 to US$ 298 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Influenza Virus Rapid Antigen Test Kit Market

Influenza Virus Rapid Antigen Test Kit Market

The Influenza Virus Rapid Antigen Test Kit is a diagnostic tool designed for the rapid detection of influenza virus antigens in patient samples. Utilizing specific antibodies, this kit enables healthcare professionals to quickly screen for the presence of influenza virus, aiding in the timely diagnosis and management of influenza infections. This rapid antigen test kit provides a convenient and efficient method for frontline healthcare workers to identify influenza cases, facilitating prompt treatment and containment measures during flu outbreaks.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Influenza Virus Rapid Antigen Test Kit leading manufacturers including BD, Abbott, Quidel, Roche, Actim, Denka, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, etc., dominate supply; the top five capture approximately % of global revenue, with BD leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Influenza Virus Rapid Antigen Test Kit market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Influenza Virus Rapid Antigen Test Kit Market Report

Report Metric Details
Report Name Influenza Virus Rapid Antigen Test Kit Market
Accounted market size in 2024 US$ 223 million
Forecasted market size in 2031 US$ 298 million
CAGR 4.3%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • Conventional RIDT
  • Digital RIDT
Segment by Application
  • Hospital
  • POCT
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BD, Abbott, Quidel, Roche, Actim, Denka, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, Daan Gene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Influenza Virus Rapid Antigen Test Kit study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Influenza Virus Rapid Antigen Test Kit Market growing?

Ans: The Influenza Virus Rapid Antigen Test Kit Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Influenza Virus Rapid Antigen Test Kit Market size in 2031?

Ans: The Influenza Virus Rapid Antigen Test Kit Market size in 2031 will be US$ 298 million.

Who are the main players in the Influenza Virus Rapid Antigen Test Kit Market report?

Ans: The main players in the Influenza Virus Rapid Antigen Test Kit Market are BD, Abbott, Quidel, Roche, Actim, Denka, Guangzhou Wondfo Biotech, Jiangsu Bioperfectus Technologies, Hangzhou Biotest Biotech, Wantai BioPharm, Daan Gene

What are the Application segmentation covered in the Influenza Virus Rapid Antigen Test Kit Market report?

Ans: The Applications covered in the Influenza Virus Rapid Antigen Test Kit Market report are Hospital, POCT, Others

What are the Type segmentation covered in the Influenza Virus Rapid Antigen Test Kit Market report?

Ans: The Types covered in the Influenza Virus Rapid Antigen Test Kit Market report are Conventional RIDT, Digital RIDT

1 Study Coverage
1.1 Introduction to Influenza Virus Rapid Antigen Test Kit: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Influenza Virus Rapid Antigen Test Kit Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Conventional RIDT
1.2.3 Digital RIDT
1.3 Market Segmentation by Application
1.3.1 Global Influenza Virus Rapid Antigen Test Kit Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 POCT
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Influenza Virus Rapid Antigen Test Kit Revenue Estimates and Forecasts 2020-2031
2.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Influenza Virus Rapid Antigen Test Kit Sales Estimates and Forecasts 2020-2031
2.4 Global Influenza Virus Rapid Antigen Test Kit Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Influenza Virus Rapid Antigen Test Kit Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Influenza Virus Rapid Antigen Test Kit Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Conventional RIDT Market Size by Manufacturers
3.5.2 Digital RIDT Market Size by Manufacturers
3.6 Global Influenza Virus Rapid Antigen Test Kit Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Influenza Virus Rapid Antigen Test Kit Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Influenza Virus Rapid Antigen Test Kit Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Influenza Virus Rapid Antigen Test Kit Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Influenza Virus Rapid Antigen Test Kit Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Type (2020-2031)
6.4 North America Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Influenza Virus Rapid Antigen Test Kit Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Type (2020-2031)
7.4 Europe Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Influenza Virus Rapid Antigen Test Kit Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Influenza Virus Rapid Antigen Test Kit Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Type (2020-2031)
9.4 Central and South America Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Influenza Virus Rapid Antigen Test Kit Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Influenza Virus Rapid Antigen Test Kit Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 BD
11.1.1 BD Corporation Information
11.1.2 BD Business Overview
11.1.3 BD Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.1.4 BD Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 BD Influenza Virus Rapid Antigen Test Kit Sales by Product in 2024
11.1.6 BD Influenza Virus Rapid Antigen Test Kit Sales by Application in 2024
11.1.7 BD Influenza Virus Rapid Antigen Test Kit Sales by Geographic Area in 2024
11.1.8 BD Influenza Virus Rapid Antigen Test Kit SWOT Analysis
11.1.9 BD Recent Developments
11.2 Abbott
11.2.1 Abbott Corporation Information
11.2.2 Abbott Business Overview
11.2.3 Abbott Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.2.4 Abbott Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Abbott Influenza Virus Rapid Antigen Test Kit Sales by Product in 2024
11.2.6 Abbott Influenza Virus Rapid Antigen Test Kit Sales by Application in 2024
11.2.7 Abbott Influenza Virus Rapid Antigen Test Kit Sales by Geographic Area in 2024
11.2.8 Abbott Influenza Virus Rapid Antigen Test Kit SWOT Analysis
11.2.9 Abbott Recent Developments
11.3 Quidel
11.3.1 Quidel Corporation Information
11.3.2 Quidel Business Overview
11.3.3 Quidel Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.3.4 Quidel Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Quidel Influenza Virus Rapid Antigen Test Kit Sales by Product in 2024
11.3.6 Quidel Influenza Virus Rapid Antigen Test Kit Sales by Application in 2024
11.3.7 Quidel Influenza Virus Rapid Antigen Test Kit Sales by Geographic Area in 2024
11.3.8 Quidel Influenza Virus Rapid Antigen Test Kit SWOT Analysis
11.3.9 Quidel Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Business Overview
11.4.3 Roche Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.4.4 Roche Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Roche Influenza Virus Rapid Antigen Test Kit Sales by Product in 2024
11.4.6 Roche Influenza Virus Rapid Antigen Test Kit Sales by Application in 2024
11.4.7 Roche Influenza Virus Rapid Antigen Test Kit Sales by Geographic Area in 2024
11.4.8 Roche Influenza Virus Rapid Antigen Test Kit SWOT Analysis
11.4.9 Roche Recent Developments
11.5 Actim
11.5.1 Actim Corporation Information
11.5.2 Actim Business Overview
11.5.3 Actim Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.5.4 Actim Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Actim Influenza Virus Rapid Antigen Test Kit Sales by Product in 2024
11.5.6 Actim Influenza Virus Rapid Antigen Test Kit Sales by Application in 2024
11.5.7 Actim Influenza Virus Rapid Antigen Test Kit Sales by Geographic Area in 2024
11.5.8 Actim Influenza Virus Rapid Antigen Test Kit SWOT Analysis
11.5.9 Actim Recent Developments
11.6 Denka
11.6.1 Denka Corporation Information
11.6.2 Denka Business Overview
11.6.3 Denka Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.6.4 Denka Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Denka Recent Developments
11.7 Guangzhou Wondfo Biotech
11.7.1 Guangzhou Wondfo Biotech Corporation Information
11.7.2 Guangzhou Wondfo Biotech Business Overview
11.7.3 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.7.4 Guangzhou Wondfo Biotech Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Guangzhou Wondfo Biotech Recent Developments
11.8 Jiangsu Bioperfectus Technologies
11.8.1 Jiangsu Bioperfectus Technologies Corporation Information
11.8.2 Jiangsu Bioperfectus Technologies Business Overview
11.8.3 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.8.4 Jiangsu Bioperfectus Technologies Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Jiangsu Bioperfectus Technologies Recent Developments
11.9 Hangzhou Biotest Biotech
11.9.1 Hangzhou Biotest Biotech Corporation Information
11.9.2 Hangzhou Biotest Biotech Business Overview
11.9.3 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.9.4 Hangzhou Biotest Biotech Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Hangzhou Biotest Biotech Recent Developments
11.10 Wantai BioPharm
11.10.1 Wantai BioPharm Corporation Information
11.10.2 Wantai BioPharm Business Overview
11.10.3 Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.10.4 Wantai BioPharm Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Wantai BioPharm Recent Developments
11.11 Daan Gene
11.11.1 Daan Gene Corporation Information
11.11.2 Daan Gene Business Overview
11.11.3 Daan Gene Influenza Virus Rapid Antigen Test Kit Product Models, Descriptions and Specifications
11.11.4 Daan Gene Influenza Virus Rapid Antigen Test Kit Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Daan Gene Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Influenza Virus Rapid Antigen Test Kit Industry Chain
12.2 Influenza Virus Rapid Antigen Test Kit Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Influenza Virus Rapid Antigen Test Kit Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Influenza Virus Rapid Antigen Test Kit Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Influenza Virus Rapid Antigen Test Kit Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Influenza Virus Rapid Antigen Test Kit Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
BD
Abbott
Quidel
Roche
Actim
Denka
Guangzhou Wondfo Biotech
Jiangsu Bioperfectus Technologies
Hangzhou Biotest Biotech
Wantai BioPharm
DAAN Gene
List of Tables
 Table 1. Global Influenza Virus Rapid Antigen Test Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Influenza Virus Rapid Antigen Test Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Influenza Virus Rapid Antigen Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Influenza Virus Rapid Antigen Test Kit Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Influenza Virus Rapid Antigen Test Kit Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Influenza Virus Rapid Antigen Test Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Influenza Virus Rapid Antigen Test Kit Sales by Region (2020-2025) & (K Units)
 Table 8. Global Influenza Virus Rapid Antigen Test Kit Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Influenza Virus Rapid Antigen Test Kit Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Influenza Virus Rapid Antigen Test Kit Sales Share by Manufacturers (2020-2025)
 Table 12. Global Influenza Virus Rapid Antigen Test Kit Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Influenza Virus Rapid Antigen Test Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Virus Rapid Antigen Test Kit as of 2024)
 Table 16. Global Influenza Virus Rapid Antigen Test Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Influenza Virus Rapid Antigen Test Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Influenza Virus Rapid Antigen Test Kit Manufacturing Base and Headquarters
 Table 19. Global Influenza Virus Rapid Antigen Test Kit Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Influenza Virus Rapid Antigen Test Kit Sales by Type (2020-2025) & (K Units)
 Table 23. Global Influenza Virus Rapid Antigen Test Kit Sales by Type (2026-2031) & (K Units)
 Table 24. Global Influenza Virus Rapid Antigen Test Kit Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Influenza Virus Rapid Antigen Test Kit Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Influenza Virus Rapid Antigen Test Kit ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Influenza Virus Rapid Antigen Test Kit Sales by Application (2020-2025) & (K Units)
 Table 29. Global Influenza Virus Rapid Antigen Test Kit Sales by Application (2026-2031) & (K Units)
 Table 30. Influenza Virus Rapid Antigen Test Kit High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Influenza Virus Rapid Antigen Test Kit Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Influenza Virus Rapid Antigen Test Kit Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Influenza Virus Rapid Antigen Test Kit ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Influenza Virus Rapid Antigen Test Kit Growth Accelerators and Market Barriers
 Table 37. North America Influenza Virus Rapid Antigen Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Influenza Virus Rapid Antigen Test Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Influenza Virus Rapid Antigen Test Kit Growth Accelerators and Market Barriers
 Table 40. Europe Influenza Virus Rapid Antigen Test Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Influenza Virus Rapid Antigen Test Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Influenza Virus Rapid Antigen Test Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Influenza Virus Rapid Antigen Test Kit Investment Opportunities and Key Challenges
 Table 47. Central and South America Influenza Virus Rapid Antigen Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. BD Corporation Information
 Table 51. BD Description and Major Businesses
 Table 52. BD Product Models, Descriptions and Specifications
 Table 53. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. BD Sales Value Proportion by Product in 2024
 Table 55. BD Sales Value Proportion by Application in 2024
 Table 56. BD Sales Value Proportion by Geographic Area in 2024
 Table 57. BD Influenza Virus Rapid Antigen Test Kit SWOT Analysis
 Table 58. BD Recent Developments
 Table 59. Abbott Corporation Information
 Table 60. Abbott Description and Major Businesses
 Table 61. Abbott Product Models, Descriptions and Specifications
 Table 62. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Abbott Sales Value Proportion by Product in 2024
 Table 64. Abbott Sales Value Proportion by Application in 2024
 Table 65. Abbott Sales Value Proportion by Geographic Area in 2024
 Table 66. Abbott Influenza Virus Rapid Antigen Test Kit SWOT Analysis
 Table 67. Abbott Recent Developments
 Table 68. Quidel Corporation Information
 Table 69. Quidel Description and Major Businesses
 Table 70. Quidel Product Models, Descriptions and Specifications
 Table 71. Quidel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Quidel Sales Value Proportion by Product in 2024
 Table 73. Quidel Sales Value Proportion by Application in 2024
 Table 74. Quidel Sales Value Proportion by Geographic Area in 2024
 Table 75. Quidel Influenza Virus Rapid Antigen Test Kit SWOT Analysis
 Table 76. Quidel Recent Developments
 Table 77. Roche Corporation Information
 Table 78. Roche Description and Major Businesses
 Table 79. Roche Product Models, Descriptions and Specifications
 Table 80. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Roche Sales Value Proportion by Product in 2024
 Table 82. Roche Sales Value Proportion by Application in 2024
 Table 83. Roche Sales Value Proportion by Geographic Area in 2024
 Table 84. Roche Influenza Virus Rapid Antigen Test Kit SWOT Analysis
 Table 85. Roche Recent Developments
 Table 86. Actim Corporation Information
 Table 87. Actim Description and Major Businesses
 Table 88. Actim Product Models, Descriptions and Specifications
 Table 89. Actim Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Actim Sales Value Proportion by Product in 2024
 Table 91. Actim Sales Value Proportion by Application in 2024
 Table 92. Actim Sales Value Proportion by Geographic Area in 2024
 Table 93. Actim Influenza Virus Rapid Antigen Test Kit SWOT Analysis
 Table 94. Actim Recent Developments
 Table 95. Denka Corporation Information
 Table 96. Denka Description and Major Businesses
 Table 97. Denka Product Models, Descriptions and Specifications
 Table 98. Denka Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Denka Recent Developments
 Table 100. Guangzhou Wondfo Biotech Corporation Information
 Table 101. Guangzhou Wondfo Biotech Description and Major Businesses
 Table 102. Guangzhou Wondfo Biotech Product Models, Descriptions and Specifications
 Table 103. Guangzhou Wondfo Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Guangzhou Wondfo Biotech Recent Developments
 Table 105. Jiangsu Bioperfectus Technologies Corporation Information
 Table 106. Jiangsu Bioperfectus Technologies Description and Major Businesses
 Table 107. Jiangsu Bioperfectus Technologies Product Models, Descriptions and Specifications
 Table 108. Jiangsu Bioperfectus Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Jiangsu Bioperfectus Technologies Recent Developments
 Table 110. Hangzhou Biotest Biotech Corporation Information
 Table 111. Hangzhou Biotest Biotech Description and Major Businesses
 Table 112. Hangzhou Biotest Biotech Product Models, Descriptions and Specifications
 Table 113. Hangzhou Biotest Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Hangzhou Biotest Biotech Recent Developments
 Table 115. Wantai BioPharm Corporation Information
 Table 116. Wantai BioPharm Description and Major Businesses
 Table 117. Wantai BioPharm Product Models, Descriptions and Specifications
 Table 118. Wantai BioPharm Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Wantai BioPharm Recent Developments
 Table 120. Daan Gene Corporation Information
 Table 121. Daan Gene Description and Major Businesses
 Table 122. Daan Gene Product Models, Descriptions and Specifications
 Table 123. Daan Gene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Daan Gene Recent Developments
 Table 125. Key Raw Materials Distribution
 Table 126. Raw Materials Key Suppliers
 Table 127. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 128. Milestones in Production Technology Evolution
 Table 129. Distributors List
 Table 130. Market Trends and Market Evolution
 Table 131. Market Drivers and Opportunities
 Table 132. Market Challenges, Risks, and Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources


List of Figures
 Figure 1. Influenza Virus Rapid Antigen Test Kit Product Picture
 Figure 2. Global Influenza Virus Rapid Antigen Test Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Conventional RIDT Product Picture
 Figure 4. Digital RIDT Product Picture
 Figure 5. Global Influenza Virus Rapid Antigen Test Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Hospital
 Figure 7. POCT
 Figure 8. Others
 Figure 9. Influenza Virus Rapid Antigen Test Kit Report Years Considered
 Figure 10. Global Influenza Virus Rapid Antigen Test Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Influenza Virus Rapid Antigen Test Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Region (2020-2031)
 Figure 14. Global Influenza Virus Rapid Antigen Test Kit Sales (2020-2031) & (K Units)
 Figure 15. Global Influenza Virus Rapid Antigen Test Kit Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 16. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers Influenza Virus Rapid Antigen Test Kit Sales Volume Market Share in 2024
 Figure 18. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Conventional RIDT Revenue Market Share by Manufacturer in 2024
 Figure 21. Digital RIDT Revenue Market Share by Manufacturer in 2024
 Figure 22. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Type (2020-2031)
 Figure 23. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Type (2020-2031)
 Figure 24. Global Influenza Virus Rapid Antigen Test Kit Sales Market Share by Application (2020-2031)
 Figure 25. Global Influenza Virus Rapid Antigen Test Kit Revenue Market Share by Application (2020-2031)
 Figure 26. North America Influenza Virus Rapid Antigen Test Kit Sales YoY (2020-2031) & (K Units)
 Figure 27. North America Influenza Virus Rapid Antigen Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) in 2024
 Figure 29. North America Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Type (2020- 2031)
 Figure 30. North America Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Application (2020-2031)
 Figure 32. North America Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe Influenza Virus Rapid Antigen Test Kit Sales YoY (2020-2031) & (K Units)
 Figure 37. Europe Influenza Virus Rapid Antigen Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) in 2024
 Figure 39. Europe Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Type (2020-2031)
 Figure 40. Europe Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Application (2020-2031)
 Figure 42. Europe Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 44. France Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales YoY (2020-2031) & (K Units)
 Figure 49. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Type (2020- 2031)
 Figure 52. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Application (2020-2031)
 Figure 54. Asia-Pacific Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 59. India Influenza Virus Rapid Antigen Test Kit Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America Influenza Virus Rapid Antigen Test Kit Sales YoY (2020-2031) & (K Units)
 Figure 61. Central and South America Influenza Virus Rapid Antigen Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Type (2021-2031)
 Figure 64. Central and South America Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Application (2020-2031)
 Figure 66. Central and South America Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil Influenza Virus Rapid Antigen Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina Influenza Virus Rapid Antigen Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa Influenza Virus Rapid Antigen Test Kit Sales YoY (2020-2031) & (K Units)
 Figure 70. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Type (2021-2031)
 Figure 73. South America Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales Volume (K Units) by Application (2020-2031)
 Figure 75. Middle East and Africa Influenza Virus Rapid Antigen Test Kit Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries Influenza Virus Rapid Antigen Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey Influenza Virus Rapid Antigen Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt Influenza Virus Rapid Antigen Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa Influenza Virus Rapid Antigen Test Kit Revenue (2020-2025) & (US$ Million)
 Figure 80. Influenza Virus Rapid Antigen Test Kit Industry Chain Mapping
 Figure 81. Regional Influenza Virus Rapid Antigen Test Kit Manufacturing Base Distribution (%)
 Figure 82. Global Influenza Virus Rapid Antigen Test Kit Production Market Share by Region (2020-2031)
 Figure 83. Influenza Virus Rapid Antigen Test Kit Production Process
 Figure 84. Regional Influenza Virus Rapid Antigen Test Kit Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Influenza Virus Rapid Antigen Detection Kits Market Research Report 2024
Global Influenza A B Antigen Test Kit Market Research Report 2024
Global Influenza Virus Antibody Test Kits Market Research Report 2024
Global Influenza Virus Immunology Detection Kits Market Research Report 2024
Global Rapid Antigen Test Kit Market Research Report 2024
Global Rapid Antigen and Antibody Detection Kits Market Research Report 2025
Global Influenza Virus Nucleic Acid Test Kit Market Research Report 2024
Global Influenza A Antigen Detection Kit Market Research Report 2024
lnfluenza A B Fast Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Influenza A B Virus Detection Kit Market Research Report 2024
Global Monkeypox Rapid Test Kit Market Research Report 2024
Global Avian Influenza Virus Antigen Test Kit Market Research Report 2024
Global Influenza A Virus Antigen Detection Kits Market Research Report 2024
Global Hepatitis A Virus HAV Rapid Test Kit Market Research Report 2024
Global Hepatitis C Virus HCV Rapid Test Kit Market Research Report 2024
Global Hepatitis E virus HEV Rapid Test Kit Market Research Report 2024
Global Influenza A Virus Detection Reagent Market Research Report 2024
Global Parainfluenza Virus Rapid Test Kits Market Research Report 2024
Global Influenza A and B Test Kit Market Research Report 2025
Global COVID 19 Rapid Antigen Test Kits Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions